Evolocumab: No hint of added benefit
Wednesday, December 23, 2015 - 10:30
in Physics & Chemistry
The manufacturer dossier contained no suitable data for hypercholesterolaemia or for mixed dyslipidaemia, say reviewers, adding that the same applies to the hereditary homozygous form of hypercholesterolaemia.